Eben Tessari - Apr 7, 2022 Form 4 Insider Report for Kiniksa Pharmaceuticals, Ltd. (KNSA)

Role: CHIEF OPERATING OFFICER
Signature: /s/ Madelyn Zeylikman, Attorney-in-Fact
Stock symbol: KNSA
Transactions as of: Apr 7, 2022
Transactions value $: $0
Form type: 4
Date filed: 4/11/2022, 04:31 PM
Previous filing: Mar 23, 2022
Next filing: Sep 6, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KNSA	Share Option	Award	$0	+65.4K		$0.00	65.4K	Apr 7, 2022	Class A Common Share	65.4K	$11.10	Direct	F1
transaction	KNSA	Restricted Share Unit	Award	$0	+10.9K		$0.00	10.9K	Apr 7, 2022	Class A Common Share	10.9K		Direct	F2, F3

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 7, 2022.
F2	Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
F3	The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022.